BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 119882
Published online Sep 25, 2026. doi: 10.5527/wjn.119882
Table 9 The combination of these 9 microRNAs has the potential to diagnose immunoglobulin A nephropathy cases with an area under the receiver operating characteristic curve > 0.81
Discovery cohort with 9 miRNAs
hsa-miR-4532, hsa-miR-4488, hsa-miR-3158-3p, hsa-miR-151b, hsa-miR-3195, hsa-miR-1289, hsa-miR-20a-5p+hsa-miR-20b-5p, hsa-miR-32-5p, hsa-miR-525-3p
0 = Control, 1 = Disease, 2 = IgAN
ClassControl (0)Disease (1)IgAN (2)
Accuracy (95%CI)0.7692 (0.4619-0.9496)0.8462 (0.5455-0.9808)0.7692 (0.4619-0.9496)
Sensitivity0.333330.333330.8571
Specificity0.910.6667
Positive predictive value0.510.75
Negative predictive value0.818180.833330.8
Prevalence0.230770.23080.5385
Detection rate0.076920.076920.4615
Detection prevalence0.153850.076920.6154
AUC (95%CI)0.733 (0.5-0.93)1 (1-1)0.88 (0.57-1)
Kappa0.26420.43480.5301


Write to the Help Desk